EP0106828A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Recombinant DNA molecules encoding for hepatitis B surface antigen, their preparation and derived vaccines
Assignee: GlaxoSmithKline Biologicals SA
•
Filing: 1983-09-06
•
Granted: —
•
Expires: 2003-09-06
Abstract
Abstract Translated from French Un fragment d'ADN pouvant coder pour HBsAg et dérivés d'ADN de particules de Dane est fusionné à la région de régulation de gène arg3 de la levure et cloné dans un vecteur de levure. Le vecteur recombinant est utilisé pour transformer des cellules de levure compétentes dans lesquelies s'exprime le gène HBsAg. A DNA fragment capable of coding for HBsAg and DNA derivatives of Dane particles is fused to the arg3 gene regulatory region of yeast and cloned into a yeast vector. The recombinant vector is used to transform competent yeast cells in which the HBsAg gene is expressed.
Inventors
- 👤 Theresa Cabezon
- 👤 Marjolène Crabeel
- 👤 Michel De Wilde
- 👤 Nigel Harford
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-09 23:16
CPC Classifications
C; C12; C12P; C12P21/00; C07; C07K; C07K14/00; C07K14/005; A; A61; A61P; A61P31/00; A61P31/12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/80; C12N15/81; A61K; A61K38/00; C12N2730/00; C12N2730/00011; C12N2730/10011; C12N2730/10111; C12N2730/10122
Claims Analysis
Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.